August 4th, 2025 “EURETINA-Brief”© Issue No. 322
Dear EURETINA Members, A very warm welcome to the August 4th, 2025 edition of EURETINA’s web-based digital periodical, “EURETINA Brief”. EURETINA are delighted to continue…
EURETINA’s
DIGITAL
NEWSLETTER
Featured Articles
1
August 4th, 2025
Latest News
August 4th, 2025 “EURETINA-Brief”© Issue No. 322
Dear EURETINA Members, A very warm welcome to the August 4th, 2025 edition of EURETINA’s…
A small study of severe variants of ABCA4 reports a new genotype–phenotype correlation with Early-Onset Severe Retinal Dystrophy (EOSRD).
Researchers at the Department of Human Genetics, Radboud University Medical Centre, Nijmegen, the Netherlands, have…
Clinical study of >3,500 IRD patients reports novel genotype-phenotype associations using optical coherence tomography (OCT) imaging.
Clinical researchers at the Institute of Ophthalmology, University College London, UK, and Moorfields Eye Hospital…
Beacon Therapeutics announce the completion of enrolment for the Phase 2/3 trial for “laru-zova”, for the treatment of XLRP.
Beacon Therapeutics Holdings Limited, based in London, UK and Cambridge, Massachusetts, have announced the completion…